Results showed that SLC1A5 levels are significantly higher in late-stage treatment-resistant tumors from the plasma samples of 62 patients, compared to early-stage sensitive tumors, with a p-value ...
Results showed that SLC1A5 levels are significantly higher in late-stage treatment-resistant tumours from the plasma samples of 62 patients, compared to early-stage sensitive tumours, with a p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback